Next-Generation Anticoagulation Platform: Fast-Acting RNA Origami and DNA Reversal Agent Unveiled
top of page
NEWS & PUBLICATIONS
In our latest publication, we introduce a cutting-edge, optimized RNA origami platform designed for anticoagulation therapy. Building on...
Oct 10
Revolutionizing Anticoagulant Therapy: RNA Origami’s Role in Safer, Reversible Blood Thinners
Helixomer is excited to share a breakthrough that could transform anticoagulant therapies and enhance patient care. Our research...
Oct 7
Helixomer: Pioneering RNA Origami to Revolutionize Safe and Effective Anticoagulation
Helixomer is pleased to announce the publication of our patent application, introducing the first-of-its-kind RNA origami aptamer...
May 11
Innovative RNA Origami Anticoagulant Research Highlighted at MSE100 Centennial Celebration
On Friday, April 5th, Thom LaBean showcased a poster titled "Multivalent, Aptamer-Decorated RNA Origami as Direct Thrombin Inhibitor with...
Apr 5
Helixomer Inc. Secures $2 Million NIH Award for Development of Innovative Intravenous Anticoagulant and Reversal Agent
Raleigh, NC – October, 2023 – Helixomer Inc., a pioneering entity in the realm of drug development, is pleased to announce the receipt of...
Apr 4
David Harrell Appointed as New President and CEO of Helixomer
Helixomer, Inc. announces the appointment of David Harrell as President and CEO, where he will lead the company's growth efforts,...
Dec 6, 2023
WE RECENTLY PUBLISHED A PEER-REVIEWED RESEARCH ARTICLE ON OUR RNA ANTICOAGULANT TECHNOLOGY
In the prestigious scientific journal, Advanced Materials (Impact Factor=27.4) Nucleic acid aptamers selected for thrombin binding have...
Dec 6, 2023
WE HAVE RECEIVED A CHANCELLOR’S INNOVATION FUND (CIF) AWARD
The funding has allowed us to pursue pre-clinical evaluation of our anticoagulant and reversal agent. "As a land-grant university, our...
Dec 5, 2023
A DRAFT OF OUR NEXT PAPER HAS BEEN POSTED TO BIORXIV.
The paper has also been submitted for peer-reviewed publication. Anticoagulants are commonly utilized during surgeries and to treat...
bottom of page